Royalty Pharma (RPRX) Return on Capital Employed Growth (1y) (2021 - 2026)
Royalty Pharma (RPRX) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -1,490.00 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,629.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.41 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -310.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3,193.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 399.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -310.00 |
| Mar 31, 2026 | -308.00 |
| Dec 31, 2025 | 62.00 |
| Sep 30, 2025 | -88.00 |
| Jun 30, 2025 | 520.00 |
| Mar 31, 2025 | 553.00 |
| Dec 31, 2024 | -169.00 |
| Sep 30, 2024 | 683.00 |
| Jun 30, 2024 | 303.00 |
| Mar 31, 2024 | 225.00 |
| Dec 31, 2023 | 744.00 |
| Sep 30, 2023 | -327.00 |
| Jun 30, 2023 | -332.00 |
| Mar 31, 2023 | -463.00 |
| Dec 31, 2022 | -629.00 |
| Sep 30, 2022 | -374.00 |
| Jun 30, 2022 | -523.00 |
| Mar 31, 2022 | -110.00 |
| Dec 31, 2021 | -197.00 |
| Sep 30, 2021 | -735.00 |